We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Bayer AG

News List

AskBio’s Gene Therapy Gets Fast Track contractpharma
July 22, 2021
LION-101 is a recombinant adeno-associated virus (rAAV) based vector being developed as a one-time treatment for Limb-Girdle Muscular Dystrophy.
Bayer to team up with patient compliance start-up Pilloxa pharmatimes
March 27, 2019
Swedish start-up Pilloxa has initiated a strategic partnership with Bayer AB for an innovative smart pillbox to tackle the ever-growing problem of patient compliance.
Phase III COMPASS study with Bayer's rivaroxaban (Xarelto®) shows overwhelming efficacy and meets pr worldpharmanews
February 15, 2017
Bayer AG and its cooperation partner Janssen Research & Development, LLC have announced that the Phase III trial COMPASS evaluating the efficacy and safety of rivaroxaban (Xarelto®) for the prevention of major adverse cardiac events (MACE)...